Biochemical evaluation of endometrial function at the time of implantation

Fertility and Sterility

Volumn 78, Issue 2, 2002, Pages 221-233

  Lindhard, Anette ^a   Bentin Ley, Ursula ^b   Ravn, Vibeke ^b   Islin, Henrik ^c   Hviid, Thomas ^c   Rex, Sven ^d   Bangsboll, Susanne ^b   Sorensen, Steen ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cytokines; Endometrial receptivity; Glycodelin; Implantation; Infertility; Integrins; MUC1

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; INTEGRIN; INTERLEUKIN 1; LEUKEMIA INHIBITORY FACTOR; MUCIN 1; PLACENTA PROTEIN 14; STEROID HORMONE;

CELL SYNCHRONIZATION; CHEMICAL ANALYSIS; ENDOMETRIUM; HORMONAL REGULATION; HUMAN; INFERTILITY; NIDATION; NONHUMAN; PREGNANCY; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANIMALS; CA-15-3 ANTIGEN; CYTOKINES; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GLYCOPROTEINS; GROWTH INHIBITORS; HUMANS; INFERTILITY, FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MACROPHAGE COLONY-STIMULATING FACTOR; MENSTRUATION; MODELS, ANIMAL; PREGNANCY PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF;

EID: 0036321668     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03240-5     Document Type: Review

References (100)

1. Implantation and the placenta: Key pieces of the development puzzle
2. Potential biochemical markers of uterine receptivity
3. Leukemia inhibitory factor
4. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
5. Recombinant human leukemia inhibitory factor enhances the development of preimplantation mouse embryo in vitro
6. Paracrine induction of stem cell renewal by LIF-deficient cells: A new ES cell regulatory pathway
7. The effect of leukemia inhibitory factor (LIF) on trophoblast differentiation: A potential role in human implantation
8. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor
9. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
10. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation
11. The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture
12. Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy
13. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions
14. Preimplantation development of the mammalian embryo and its regulation by growth factors
15. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos
16. Effect of human chorionic gonadotropin on cytokine production from human endometrial cells in vitro
17. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis
18. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice
19. In-vivo administration of progesterone inhibits the secretion of endometrial leukaemia inhibitory factor in vitro
20. Leukaemia inhibitory factor gene mutations in infertile women
21. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy
22. Macrophage growth and stimulating factor, M-CSF
23. Structure-function studies of a colony stimulating factor (CSF-1)
24. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor
25. Human CSF-1: Gene structure and alternative splicing of mRNA precursors
26. Human macrophage-colony stimulating factor: Alternative RNA and protein processing from a single gene
27. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility
28. Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice disrupts estrous cycles and ovulation
29. CSF-1 and mouse preimplantation development in vitro
30. Human macrophage colony-stimulating factor induces the differentiation of trophoblast
31. Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy
32. Colony stimulating factor-1 concentrations in blood and follicular fluid during the human menstrual cycle and ovarian stimulation: Possible role in the ovulatory process
33. Low serum M-CSF levels are associated with unexplained recurrent abortion
34. Detection of IL-1 alpha and IL-1 beta gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse
35. Different pattern of interleukin-1 beta- (IL-1 beta), interleukin-1 receptor antagonist- (IL-1ra) and interleukin-1 receptor type I- (IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages
36. Expression of interleukin 1, interleukin 6 and tumour necrosis factor alpha in mouse uterus during the peri-implantation period of pregnancy
37. The expression of interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor type I mRNA during preimplantation mouse development
38. Production of interleukin-1, interleukin-6, and tumor necrosis factor alpha in the uterus of pseudopregnant mice
39. Reproduction in mice lacking a functional type 1 IL-1 receptor
40. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist
41. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium
42. The cytoskeleton of uterine epithelial cells: A new player in uterine receptivity and the plasma membrane transformation
43. Localization of interleukin-1 type I receptor and interleukin-1 beta in human endometrium throughout the menstrual cycle
44. Selective localization of interleukin-1 receptor antagonist in eutopic endometrium and endometriotic implants
45. Embryonic regulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro
46. Expression of interleukin-1 system mRNA in single blastomeres from human preimplantation embryos
47. 2 production
48. Human decidual cell biosynthesis of leukemia inhibitory factor: Regulation by decidual cytokines and steroid hormones
49. Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro
50. Determination of IL-1 and IL-6 levels in human embryo culture-conditioned media
51. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy
52. Distribution of cell adhesion molecules in decidua of early human pregnancy. An immunohistochemical study
53. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle
54. Integrins beta 5, beta 3 and alpha v are apically distributed in endometrial epithelium
55. Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: Implications for implantation, contraception, and infertility
56. Cell adhesion molecules on the oocyte and preimplantation human embryo
57. Osteopontin in human endometrium: A role in endometrial receptivity and embryo implantation?
58. Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation
59. Modulation of integrin expression in endometrial stromal cells in vitro
60. Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells
61. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
62. Aberrant integrin expression in the endometrium of women with endometriosis
63. Integrins as markers of uterine receptivity in women with primary unexplained infertility
64. Hydrosalpinges adversely affect markers of endometrial receptivity
65. Hydrosalpinx and IVF outcome: A prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF
66. Hydrosalpinx fluid does not adversely affect the normal development of human embryos and implantation in vitro
67. Blockade of the alpha(v)beta(3) integrin adversely affects implantation in the mouse
68. Glycodelins
69. Factors affecting fertilization: Endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida
70. Suppression by human placental protein 14 of natural killer cell activity
71. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles
72. Placental protein 14 levels in uterine flushing and plasma of women with unexplained infertility
73. Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients
74. An analysis of the variation of plasma concentrations of placental protein 14 in artificial cycles
75. Circulating placental protein 14: In the first trimester of spontaneous and IVF pregnancies
76. Serum placental protein 14 concentrations are similar in the first trimester pregnancies of women after pituitary down-regulation with a gonadotrophin-releasing hormone agonist and normal cycles with frozen embryo transfers
77. Serum placental protein 14 concentrations in the first trimester of ovum donation pregnancies
78. Placental protein 14 in cycles with normal and retarded endometrial differentiation
79. Immunohistochemical expression of endometrial proteins and pregnancy outcome in frozen embryo replacement cycles
80. Dating the endometrial biopsy
81. The correlation of placental protein 14 concentrations in uterine flushing and endometrial morphology in the peri-implantation period
82. Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women
83. Concentrations of placental protein 14 in uterine flushings from infertile women: Validation of the collection technique and method of expression of results
84. The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase
85. Regional specialization of the cell membrane-associated, polymorphic mucin (MUC1) in human uterine epithelia
86. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin
87. The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM
88. MUC 1: A genetic susceptibility to infertility?
89. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components
90. Sialyl-Lewis x and Sialyl-Lewis a are associated with MUC1 in human endometrium
91. Expression and steroid hormonal control of Muc-1 in the mouse uterus
92. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst
93. Progesterone and implanting blastocysts regulate Muc1 expression in rabbit uterine epithelium
94. Human endometrial MUC1 carries keratan sulfate: Characteristic glycoforms in the luminal epithelium at receptivity
95. MUC1 in secretory phase endometrium: Expression in precisely dated biopsies and flushings from normal and recurrent miscarriage patients
96. MUC1 as a cell surface and secretory component of endometrial epithelium: Reduced levels in recurrent miscarriage
97. The distribution of type-2 chain histo-blood group antigens in normal cycling human endometrium
98. The distribution of type 1 chain ABH and related histo-blood group antigens in normal cycling human endometrium
99. The milk oligosaccharide, lacto-N-fucopentaose I, inhibits attachment of mouse blastocysts on endometrial monolayers
100. Glycans as biochemical markers of human endometrial secretory differentiation